Smith Thomas B
EVP and Chief Medical Officer at COLL; Chief Medical Officer at BIODELIVERY SCIENCES INTERNATIONAL INC
- Sold, on record
- $1.1M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Aug 29, 2025
- Form 144 notices
- 3
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- COLLCOLLEGIUM PHARMACEUTICAL, INCEVP and Chief Medical Officer
- BIODELIVERY SCIENCES INTERNATIONAL INCChief Medical Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- COLL28,066 shares
- BIODELIVERY SCIENCES INTERNATIONAL INC2,927 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale BIODELIVERY SCIENCES INTERNATIONAL INCUnusualJan 31, 2020 2020
Sold 2,927 shares at $5.38 ($16k)
Smith Thomas B, Chief Medical Officer
Sold 38.2% of holdings ($41k position)4,739 shares leftFirst sale on recordFiling
- 2 Form 144 notice COLLNoticeFeb 29, 2024 +1490 days
Filed to sell 995 shares ($37k)
Smith Thomas B, Officer
No 10b5-1 planFirst sale on recordFiling
- 3 Form 4 sale COLLNo planFeb 29, 2024 same day
Sold 995 shares at $36.76 ($37k)
Smith Thomas B, EVP and Chief Medical Officer
No 10b5-1 planSold 1.5% of holdings ($2.4M position)63,409 shares leftFirst sale on recordFollows a Form 144Filing
- 4 Form 144 notice COLLNoticeSep 13, 2024 +197 days
Filed to sell 9,220 shares ($338k)
Smith Thomas B, Officer
No 10b5-1 planFiling
- 5 Form 144 notice COLLNoticeSep 13, 2024 same day
Filed to sell 373 shares ($14k)
Smith Thomas B, Officer
No 10b5-1 planFiling
- 6 Form 4 sale COLLNo planSep 13, 2024 same day
Sold 9,593 shares at $36.62 ($351k)
Smith Thomas B, EVP and Chief Medical Officer
No 10b5-1 planSold 15.1% of holdings ($2.3M position)53,816 shares leftFollows a Form 144Filing
- 7 Form 4 sale COLLNo planAug 29, 2025 +350 days
Sold 17,478 shares at $38.42 ($672k)
Smith Thomas B, EVP and Chief Medical Officer
No 10b5-1 planSold 19.9% of holdings ($3.4M position)70,264 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (7)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 29, 2025 | Sep 3, 2025 | COLL | EVP and Chief Medical Officer | Form 4 sale | 17,478 | $672k | 19.9% | No plan | SEC |
| Sep 13, 2024 | Sep 17, 2024 | COLL | EVP and Chief Medical Officer | Form 4 sale | 9,593 | $351k | 15.1% | No plan | SEC |
| Sep 13, 2024 | Sep 13, 2024 | COLL | Officer | Form 144 notice | 373 | $14k | Notice | SEC | |
| Sep 13, 2024 | Sep 13, 2024 | COLL | Officer | Form 144 notice | 9,220 | $338k | Notice | SEC | |
| Feb 29, 2024 | Mar 4, 2024 | COLL | EVP and Chief Medical Officer | Form 4 sale | 995 | $37k | 1.5% | No plan | SEC |
| Feb 29, 2024 | Feb 29, 2024 | COLL | Officer | Form 144 notice | 995 | $37k | Notice | SEC | |
| Jan 31, 2020 | Feb 4, 2020 | BIODELIVERY SCIENCES INTERNATIONAL INC | Chief Medical Officer | Form 4 sale | 2,927 | $16k | 38.2% | Unusual | SEC |